Found on pharmacist.com
Group by:
Title Date Type
Weekly Open Forum Webinars
  Addressing the COVID-19 Crisis: An Open Forum Webinar Series for Pharmacists are weekly webinars conducted every Thursday from 1:00 pm–2:00 pm ET. Each open forum webinar is moderated by APhA President Michael Hogue.   Register for the APhA Weekly Open Forum Webinar (August 13)…
Jul 30, 2020 Basic page
Trump signs executive order to boost U.S. production of essential medicine
Wall Street Journal (08/06/20) Levy, Rachael; Hopkins, Jared S.
President Trump has signed an executive order aimed at boosting U.S. production of medicines, medical equipment, and protective gear. "We will bring our pharmaceutical and medical supply chains home—we're going to bring them home where they belong—and we will end reliance on China,"…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
Ofatumumab vs. teriflunomide in multiple sclerosis
New England Journal of Medicine (08/06/20) Vol. 383, No. 6, P. 546 Hauser, Stephen L.; Bar-Or, Amit; Cohen, Jeffrey A.; et al.
The ASCLEPIOS I and ASCLEPIOS II clinical trials compared outcomes in multiple sclerosis patients treated with ofatumumab vs. teriflunomide. Collectively, the Phase III studies randomized 946 patients with relapsing disease to receive subcutaneous ofatumumab, an anti-CD20 monoclonal antibody that…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
FDA approves GSK's belantamab mafodotin-blmf for relapsed or refractory multiple myeloma
Business Wire (08/05/20)
FDA has approved belantamab mafodotin-blmf (Blenrep—GlaxoSmithKline) as a monotherapy for adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
Ferring US issues recall of desmopressin nasal spray due to superpotency
FDA Recalls, Market Withdrawals, & Safety Alerts (08/05/20)
Ferring Pharmaceuticals US announced a voluntary, nationwide recall of DDAVP nasal spray 10 mcg/0.1mL, desmopressin acetate nasal spray 10 mcg/0.1mL, and STIMATE nasal spray 1.5 mg/mL after routine testing found levels of desmopressin higher than specified. The risks associated with superpotency…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
APhA to Americans: Take simple actions to save lives during pandemic
Drug Store News (08/06/20) Levy, Sandra
In an open letter to the public, APhA's board of trustees is calling on the public to take simple actions that save lives, as the number of confirmed COVID-19 cases continues to rise. These actions include washing hands frequently, practicing physical distancing, and wearing a face covering. "…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
HHS awards over $101 million to combat the opioid crisis
HHS News Release (08/06/20)
HHS' Health and Resources and Services Administration (HRSA) has awarded more than $101 million to several entities to help curb substance use disorders (SUD) and opioid use disorders (OUD). Overall, the awards support 116 organizations across 42 states and the District of Columbia. HRSA's Federal…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
Patient and plan spending after state specialty-drug out-of-pocket spending caps
New England Journal of Medicine (08/06/20) Vol. 383, No. 6, P. 558 Yeung, Kai; Barthold, Douglas; Dusetzina, Stacie B.; et al.
Researchers examined how limiting out-of-pocket costs on specialty drugs affects spending by both patients and health plans. Medications to treat complex or potentially fatal conditions typically are expensive; but capping costs could shift the financial burden to health plans, which in turn could…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
COVID-19 vaccine makers signal prices
Wall Street Journal (08/05/20) Loftus, Peter
Some companies developing COVID-19 vaccines on Wednesday revealed the prices they intend to charge for the vaccines, ranging from $10 to $37 a dose. Johnson & Johnson said it agreed to provide 100 million doses of its vaccine for use in the United States in exchange for more than $1 billion…
Aug 06, 2020 Publication Pharmacy Today Daily Edition
Pandemic lays bare U.S. reliance on China for drugs
Wall Street Journal (08/05/20) Yap, Chuin-Wei
The shortage of acetaminophen for weeks this spring highlights the nation's reliance on China for active pharmaceutical ingredients (APIs). The Commerce Department and analysts estimate that China manufactures roughly 70% of the acetaminophen used in the United States. In an effort to reduce the…
Aug 06, 2020 Publication Pharmacy Today Daily Edition